Cspc Pharmaceutical Group Stock Performance
| CHJTF Stock | USD 0.67 0.16 19.28% |
On a scale of 0 to 100, CSPC Pharmaceutical holds a performance score of 3. The firm shows a Beta (market volatility) of -1.56, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning CSPC Pharmaceutical are expected to decrease by larger amounts. On the other hand, during market turmoil, CSPC Pharmaceutical is expected to outperform it. Please check CSPC Pharmaceutical's maximum drawdown, as well as the relationship between the daily balance of power and price action indicator , to make a quick decision on whether CSPC Pharmaceutical's price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CSPC Pharmaceutical Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly sluggish basic indicators, CSPC Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 7.3 B | |
| Total Cashflows From Investing Activities | -637.3 M |
CSPC |
CSPC Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 61.00 in CSPC Pharmaceutical Group on August 26, 2024 and sell it today you would earn a total of 6.00 from holding CSPC Pharmaceutical Group or generate 9.84% return on investment over 90 days. CSPC Pharmaceutical Group is currently producing 0.3863% returns and takes up 7.7554% volatility of returns over 90 trading days. Put another way, 69% of traded pink sheets are less volatile than CSPC, and 93% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CSPC Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CSPC Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CSPC Pharmaceutical Group, and traders can use it to determine the average amount a CSPC Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0498
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CHJTF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.76 actual daily | 69 69% of assets are less volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average CSPC Pharmaceutical is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CSPC Pharmaceutical by adding it to a well-diversified portfolio.
CSPC Pharmaceutical Fundamentals Growth
CSPC Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CSPC Pharmaceutical, and CSPC Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CSPC Pink Sheet performance.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 11.19 B | |||
| Shares Outstanding | 11.93 B | |||
| Price To Earning | 14.83 X | |||
| Price To Book | 3.41 X | |||
| Price To Sales | 0.45 X | |||
| Revenue | 27.87 B | |||
| EBITDA | 7.72 B | |||
| Cash And Equivalents | 13.97 B | |||
| Cash Per Share | 1.17 X | |||
| Total Debt | 682.56 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 2.35 X | |||
| Cash Flow From Operations | 4.64 B | |||
| Earnings Per Share | 0.07 X | |||
| Total Asset | 34.74 B | |||
About CSPC Pharmaceutical Performance
By analyzing CSPC Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into CSPC Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CSPC Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CSPC Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. Cspc Pharmaceuticals operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 25147 people.Things to note about CSPC Pharmaceutical performance evaluation
Checking the ongoing alerts about CSPC Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CSPC Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CSPC Pharmaceutical had very high historical volatility over the last 90 days | |
| CSPC Pharmaceutical has some characteristics of a very speculative penny stock | |
| About 30.0% of the company shares are held by company insiders |
- Analyzing CSPC Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CSPC Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining CSPC Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CSPC Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CSPC Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CSPC Pharmaceutical's pink sheet. These opinions can provide insight into CSPC Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CSPC Pink Sheet analysis
When running CSPC Pharmaceutical's price analysis, check to measure CSPC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSPC Pharmaceutical is operating at the current time. Most of CSPC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CSPC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSPC Pharmaceutical's price. Additionally, you may evaluate how the addition of CSPC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |